Gene · 900
Papers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Effect of a School-Based Intervention on Children's Cycling Knowledge, Mode of Commuting and Perceived Barriers: A Randomized Controlled Trial. | Int J Environ Res Public Health | 2022 | 35954982 | PubTator, text mining | PubMed |
| Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35945536 | PubTator, text mining | PubMed |
| miRNA-23b-5p affects the proliferation, migration and invasion of osteosarcoma by targeting TMEM127. | Discov Oncol | 2022 | 35941331 | PubTator, text mining | PubMed |
| PSA provocation by bipolar androgen therapy may predict duration of response to first-line androgen deprivation: Updated results from the BATMAN study. | Prostate | 2022 | 35938545 | PubTator, text mining | PubMed |
| The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35924150 | PubTator, text mining | PubMed |
| Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy. | Drug Deliv | 2022 | 35915054 | PubTator, text mining | PubMed |
| Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma. | Front Oncol | 2022 | 35912267 | PubTator, text mining | PubMed |
| Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma. | Front Oncol | 2022 | 35912172 | PubTator, text mining | PubMed |
| Mitochondrial Deep Dive into Hematopoietic Stem Cell Dormancy: Not Much Glycolysis but Plenty of Sluggish Lysosomes. | Exp Hematol | 2022 | 35908627 | PubTator, text mining | PubMed |
| Examining the Effect of Increased Aerobic Exercise in Moderately Fit Adults on Psychological State and Cognitive Function. | Front Hum Neurosci | 2022 | 35903787 | PubTator, text mining | PubMed |
| ECG Approximate Entropy in the Elderly during Cycling Exercise. | Sensors (Basel) | 2022 | 35890935 | PubTator, text mining | PubMed |
| MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma. | Biomolecules | 2022 | 35883486 | PubTator, text mining | PubMed |
| The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation. | Mol Brain | 2022 | 35883152 | PubTator, text mining | PubMed |
| Does Physical Activity in Natural Outdoor Environments Improve Wellbeing? A Meta-Analysis. | Sports (Basel) | 2022 | 35878114 | PubTator, text mining | PubMed |
| Current approaches of nanomedicines in the market and various stage of clinical translation. | Acta Pharm Sin B | 2022 | 35865096 | PubTator, text mining | PubMed |
| Protection is not always a good thing: The immune system's impact on gene therapy. | Genet Mol Biol | 2022 | 35852088 | PubTator, text mining | PubMed |
| Differential Expression Profiles of mRNA and Noncoding RNA and Analysis of Competitive Endogenous RNA Regulatory Networks in Nonalcoholic Steatohepatitis. | Gastroenterol Res Pract | 2022 | 35844837 | PubTator, text mining | PubMed |
| Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review. | Nutrients | 2022 | 35807785 | PubTator, text mining | PubMed |
| Role of Ape1 in Impaired DNA Repair Capacity in Battery Recycling Plant Workers Exposed to Lead. | Int J Environ Res Public Health | 2022 | 35805621 | PubTator, text mining | PubMed |
| Performance evaluation of a non-invasive one-step multiplex RT-qPCR assay for detection of SARS-CoV-2 direct from saliva. | Sci Rep | 2022 | 35798820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/900/papers?page=15